ESM1 and metabolic dysfunction-associated steatotic liver disease: In this present study, we demonstrated low serum concentrations of endocan in patients with metabolic syndrome with NAFLD in comparison with healthy individuals, which gives an insight into the role of endocan in NAFLD.